home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 22, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries

InvivoGen

10515 Vista Sorrento Pkwy
San Diego, 92121
United States of America, California
Toll free: 888.457.5873

Phone: 858.457.5873
Fax: 858.457.5843

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

InvivoGen develops and commercializes high quality reagents and services for scientific research in life sciences.

InvivoGen is a leading supplier of products for the study of innate immunityOur products include PRR ligandsinhibitorsantibodiesreporter cell linesexpression vectors and recombinant proteins.

InvivoGen also offers a large choice of selection antibiotics for gene delivery experiments including hygromycin, blasticidin, G418, and Zeocin™, as well as antimicrobial antibiotics such as the renowned mycoplasma removal agent, Plasmocin™.

InvivoGen has become a specialist in antibody engineering providing biosimilar antibodies with various IgG formats, mouse anti-mouse antibodies and cloning vectors designed for the generation of recombinant antibodies. Our collection of antibodies targets innate immune sensors, cytokines, tumor antigens and immune checkpoints.

 



Selected Categories:
Product Company   Service Company
Biotech
- Research
Diagnostics
- in vitro
- Miscellaneous
Supplier
- Laboratory
- Research
Contract
- Production
- Research

Last update of this entry: October 25, 2022

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.